This study is looking at whether using Airsupra, an inhaler containing both albuterol and budesonide, can help prevent asthma attacks from coming back after you've been treated in the emergency department (ED) for acute asthma. Researchers want to see if starting Airsupra when you leave the ED can reduce how often you need to return for asthma treatment over the next three months. You might be able to join if you are 18 to 54 years old, have acute asthma, speak English or Spanish, and your ED doctor plans to send you home with a short course of steroids. If you are in the group using Airsupra, you'll need to be willing to use it as your rescue inhaler for three months and show you can use an inhaler correctly. The study aims to enroll about 1860 people, but its current status is unclear.

Study design

This is a randomized controlled trial, meaning participants will be assigned by chance to different groups. The study plans to enroll approximately 1860 participants.

What's involved

If you are in the intervention group, you would use Airsupra as your rescue inhaler for three months. You would also need to demonstrate acceptable inhaler technique.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome, acute asthma recurrence, will be measured at 3 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.